Skip to content
LLYEli Lilly and Company

LLY Earnings

Eli Lilly and Company next reports earnings on October 29, 2026. Track record: 4/4 beats.

Earnings Reported

October 29, 2026

Current Price

$1,417.54

EPS Estimate

Earnings Per Share

$11.12

+47.4% YoY

Trailing EPS

Last 12 months earnings

$29.79

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

28.9

Margin: 31.9%

Analyst Rating

Buy

29 analysts

Analyst Sentiment

Buy29 analysts
Target: $1,377.71-2.8%Full analysis →

Trading above average target while rated "Buy." Price may have rallied faster than analysts updated targets.

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-09-30$6.35$7.48+17.9%Beat
2026-06-30$6.58$8.38+27.3%Beat
2026-03-31$6.79$8.55+25.9%Beat
2025-12-31$6.91$7.54+9.1%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$11.12+47.4%
Next Qtr(+1q)$10.46+22.4%
Current Year(0y)$35.08+44.9%
Next Year(+1y)$49.09+40.0%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$11.12

Revenue Estimate

$24.5B

Annual EPS Est.

$35.08

+44.9% YoY

LLY Earnings FAQ

When is LLY's next earnings date?

Eli Lilly and Company (LLY) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $11.12.

Does LLY usually beat earnings estimates?

Eli Lilly and Company has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is LLY's trailing EPS?

Eli Lilly and Company's trailing twelve-month EPS is $29.79. This is calculated from the last four quarters of reported earnings.

What do analysts think about LLY?

29 Wall Street analysts cover Eli Lilly and Company. The consensus rating is "Buy" with an average price target of $1,377.71, implying 2.8% downside from the current price.